Sirolimus Attenuates the Rate of Progression of Early Chronic Allograft Nephropathy

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3470-3472

  Sumethkul, V ^a   Changsirikulchai, S ^b   Lothuvachai, T ^a   Chalermsanyakorn, P ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN;

ADULT; ARTICLE; ATTENUATION; BLOOD PRESSURE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DRUG BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY BIOPSY; LINEAR REGRESSION ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; RANK SUM TEST; RATING SCALE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AZATHIOPRINE; BIOPSY; BLOOD PRESSURE; CHRONIC DISEASE; CREATININE; CYCLOSPORINE; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; SIROLIMUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33845452280     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.097     Document Type: Article

References (6)

1. Diekmann F., Budde K., Oppenheimer F., et al. Predictors of success in conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction. Am J Transplant 4 (2004) 1869
2. Groetzner J., Meiser B., Landwehr P., et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor free immunosuppression for late cardiac transplant recipients with chronic renal failure. Transplantation 77 (2004) 568
3. Saunders R.N., Bicknell G.R., Nicholson M.L., et al. The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy. Transplantation 75 (2003) 741
4. Nankivell B.J., Borrows R.J., Fung C.L., et al. The natural history of chronic allograft nephropathy. N Engl J Med 349 (2003) 2326
5. White C., Akbari A., Hussain N., et al. Estimating glomerular filtration rate in kidney transplantation: A comparison between serum creatinine and Cystatin C based methods. J Am Soc Nephrol 16 (2005) 3763
6. Ruiz J.C., Diekmann F., Campistol J.M., et al. Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study. Transplant Proc 37 (2005) 3833